Indoleamine-2, 3-dioxygenase (IDO) is a rate-limiting enzyme that controls tryptophan catabolism in tumor cells and MDSCs within the TME, which is recognized as an important microenvironmental factor that impairs cytotoxic T cell responses and survival (Schafer et al., 2016). Here, IDO1 is linked to neoplasm.